Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-07-15 20:27 Tx date 2024-07-12 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$100,000 vol |
$100,000 | |
Filed 2024-07-15 20:27 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-07-15 20:25 Tx date 2024-07-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$600,000 vol |
$905,000 | |
Filed 2024-04-16 16:04 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
828,290 | |
Filed 2024-04-16 16:03 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
Filed 2024-04-16 16:03 Tx date 2019-07-22 |
$PCLO
PharmaCielo Ltd. |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-16 16:00 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+750,000 vol |
750,000 | |
Filed 2024-04-16 15:59 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-16 15:59 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+125,000 vol |
125,000 | |
Filed 2024-04-16 15:58 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
535,000 | |
Filed 2024-04-16 15:56 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+125,000 vol |
125,000 | |
Filed 2024-04-16 15:55 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+266,119 vol |
266,119 | |
Filed 2024-04-16 15:55 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-16 15:54 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
2,152,900 | |
Filed 2024-04-16 15:53 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+529,829 vol |
529,829 | |
Filed 2024-04-16 15:52 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-16 15:31 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,098,300 | |
Filed 2024-04-16 15:30 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+300,000 vol |
300,000 | |
Filed 2024-04-16 15:29 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-01-17 11:23 Tx date 2024-01-17 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,642.6538
-57,298 vol $0.2381 each |
545,646 | |
Filed 2024-01-16 12:06 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+78,737 vol |
||
Filed 2024-01-16 12:06 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+466,504 vol |
||
Filed 2024-01-16 12:03 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,751 vol |
||
Filed 2023-04-05 10:39 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+466,504 vol |
||
Filed 2023-04-05 10:34 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,751 vol |
||
Filed 2023-04-05 10:26 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+78,737 vol |
||
Filed 2024-01-10 12:50 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$96,512
+501,364 vol $0.1925 each |
1,303,176 | |
Filed 2024-01-10 12:49 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$18,398
+95,577 vol $0.1925 each |
4,504,566 | |
Filed 2024-01-10 12:48 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$62,044
+322,308 vol $0.1925 each |
4,098,497 | |
Filed 2024-01-10 12:47 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$11,029
+57,298 vol $0.1925 each |
602,944 | |
Filed 2024-01-09 21:24 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$25,000 vol |
$2,105,000 | |
Filed 2024-01-09 21:24 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
957,500 | |
Filed 2024-01-09 21:23 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+115,000 vol |
162,500 | |
Filed 2024-01-09 21:20 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$115,000 vol |
$305,000 | |
Filed 2023-10-20 19:55 Tx date 2023-08-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$550,000 vol |
$2,080,000 | |
Filed 2023-07-21 11:24 Tx date 2023-07-19 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,030,576 vol |
3,776,189 | |
Filed 2023-07-21 11:23 Tx date 2023-07-19 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,030,576 vol |
0 | |
Filed 2023-06-30 10:01 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,969
+55,040 vol $0.1993 each |
545,646 | |
Filed 2023-06-30 10:00 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$61,705
+309,609 vol $0.1993 each |
1,745,613 | |
Filed 2023-06-30 09:59 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,808
+9,072 vol $0.1993 each |
801,812 | |
Filed 2023-06-30 09:59 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,787
+13,987 vol $0.1993 each |
792,740 | |
Filed 2023-06-30 09:58 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$759.33
+3,810 vol $0.1993 each |
778,753 | |
Filed 2023-06-30 09:58 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$53,076
+266,316 vol $0.1993 each |
774,943 | |
Filed 2023-06-12 15:56 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$80,000
+166,667 vol $0.48 each |
1,436,004 | |
Filed 2023-06-12 15:56 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-80,000.16
-166,667 vol $0.48 each |
2,030,576 | |
Filed 2023-06-12 15:50 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$250,000 vol |
$1,530,000 | |
Filed 2023-06-12 15:50 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$500,000 vol |
$1,280,000 | |
Filed 2023-06-12 15:48 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+62,500 vol |
382,500 | |
Filed 2023-06-12 15:47 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+125,000 vol |
320,000 | |
Filed 2023-04-05 10:39 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+466,504 vol |
4,408,989 | |
Filed 2023-04-05 10:37 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+466,504 vol |
||
Filed 2023-04-05 10:36 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+466,504 vol |
||
Filed 2023-04-05 10:34 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,751 vol |
410,751 | |
Filed 2023-04-05 10:34 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
410,000 | |
Filed 2023-04-05 10:28 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
798,300 | |
Filed 2023-04-05 10:26 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+78,737 vol |
1,269,337 | |
Filed 2023-04-05 10:25 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
2,027,900 | |
Filed 2023-01-18 22:33 Tx date 2023-01-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,045
+50,000 vol $0.3809 each |
508,627 | |
Filed 2023-01-18 22:32 Tx date 2023-01-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,740
+25,000 vol $0.3896 each |
458,627 | |
Filed 2023-01-18 22:31 Tx date 2023-01-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,750
+25,000 vol $0.35 each |
433,627 | |
Filed 2023-01-16 11:00 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,400
+25,000 vol $0.336 each |
408,627 | |
Filed 2023-01-16 11:00 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,495
+50,000 vol $0.3499 each |
383,627 | |
Filed 2023-01-16 10:59 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,545
+25,000 vol $0.3418 each |
333,627 | |
Filed 2023-01-16 10:59 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,290
+25,000 vol $0.3316 each |
308,627 | |
Filed 2023-01-12 12:44 Tx date 2023-01-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+25,000 vol $0.30 each |
3,942,485 | |
Filed 2023-01-12 12:43 Tx date 2023-01-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,930
+50,000 vol $0.2786 each |
3,917,485 | |
Filed 2023-01-12 12:43 Tx date 2023-01-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,790
+50,000 vol $0.2958 each |
3,867,485 | |
Filed 2023-01-11 11:47 Tx date 2023-01-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,435
+50,000 vol $0.2487 each |
283,627 | |
Filed 2023-01-11 11:46 Tx date 2023-01-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,435
+50,000 vol $0.2287 each |
233,627 | |
Filed 2023-01-11 11:46 Tx date 2023-01-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,500
+50,000 vol $0.23 each |
183,627 | |
Filed 2023-01-05 13:42 Tx date 2022-12-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+5,000 vol |
195,000 | |
Filed 2023-01-05 13:40 Tx date 2022-12-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$20,000 vol |
$780,000 | |
Filed 2022-12-16 13:57 Tx date 2022-12-15 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+52,587 vol |
1,190,600 | |
Filed 2022-12-16 13:56 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+52,587 vol |
||
Filed 2022-12-16 13:54 Tx date 2022-12-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+66,976 vol |
133,627 | |
Filed 2022-12-16 13:54 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+66,976 vol |
||
Filed 2022-12-16 13:48 Tx date 2022-12-15 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19,933 vol |
490,606 | |
Filed 2022-12-16 13:48 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19,933 vol |
||
Filed 2022-12-15 13:33 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+52,587 vol |
||
Filed 2022-12-15 13:18 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+66,976 vol |
||
Filed 2022-12-15 13:15 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19,933 vol |
||
Filed 2022-12-15 13:43 Tx date 2022-09-14 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
250,000 | |
Filed 2022-12-15 13:42 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-12-15 13:41 Tx date 2022-09-14 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Restricted Share Units
57 - Exercise of rights
|
-250,000 vol |
0 | |
Filed 2022-12-15 13:36 Tx date 2022-12-02 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+117,500 vol |
281,250 | |
Filed 2022-12-15 13:34 Tx date 2022-11-14 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$470,000 vol |
$1,125,000 | |
Filed 2022-12-15 13:33 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+52,587 vol |
1,190,600 | |
Filed 2022-12-15 13:29 Tx date 2022-12-02 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+50,000 vol |
190,000 | |
Filed 2022-12-15 13:24 Tx date 2022-11-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$200,000 vol |
$760,000 | |
Filed 2022-12-15 13:18 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+66,976 vol |
133,627 | |
Filed 2022-12-15 13:15 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19,933 vol |
490,606 | |
Filed 2022-11-30 09:28 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,800
+45,000 vol $0.44 each |
3,817,485 | |
Filed 2022-11-30 09:28 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,740
+4,000 vol $0.435 each |
3,772,485 | |
Filed 2022-11-30 09:27 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,910
+85,500 vol $0.42 each |
3,768,485 | |
Filed 2022-11-30 09:26 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,867
+4,500 vol $0.415 each |
3,682,985 | |
Filed 2022-11-30 09:26 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$410.00
+1,000 vol $0.41 each |
3,678,485 | |
Filed 2022-11-30 09:25 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+10,000 vol $0.40 each |
3,677,485 | |
Filed 2022-11-30 09:24 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+20,000 vol $0.40 each |
66,651 | |
Filed 2022-11-30 09:23 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,700
+15,000 vol $0.38 each |
46,651 | |
Filed 2022-11-30 09:23 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,290
+11,000 vol $0.39 each |
31,651 | |
Filed 2022-11-30 09:22 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,540
+4,000 vol $0.385 each |
20,651 | |
Filed 2022-11-22 21:00 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$455,000 vol |
$655,000 | |
Filed 2022-11-22 20:58 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+113,750 vol |
163,750 | |
Filed 2022-11-22 19:54 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+113,750 vol |
163,750 | |
Filed 2022-11-22 19:54 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+113,750 vol |
||
Filed 2022-11-22 19:51 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$455,000 vol |
||
Filed 2022-11-22 19:51 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$455,000 vol |
$655,000 | |
Filed 2022-11-22 19:43 Tx date 2022-10-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$430,000 vol |
$560,000 | |
Filed 2022-11-22 19:41 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+107,500 vol |
140,000 | |
Filed 2022-11-22 19:35 Tx date 2022-10-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$430,000 vol |
||
Filed 2022-11-22 19:20 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$455,000 vol $1,000 each |
||
Filed 2022-11-22 19:20 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$455,000 vol $1,000 each |
||
Filed 2022-11-22 19:10 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+113,750 vol |
||
Filed 2022-11-22 19:10 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+113,750 vol |
||
Filed 2022-10-28 19:53 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+278,290 vol |
578,290 | |
Filed 2022-10-17 15:04 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+907,900 vol |
1,427,900 | |
Filed 2022-10-17 15:03 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+923,910 vol |
2,197,243 | |
Filed 2022-10-17 15:03 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+940,000 vol |
1,273,333 | |
Filed 2022-10-17 15:01 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
590,000 | |
Filed 2022-10-17 15:00 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
3,110,000 | |
Filed 2022-10-17 14:59 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
210,000 | |
Filed 2022-10-17 14:56 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+448,300 vol |
448,300 | |
Filed 2022-10-17 14:56 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+530,000 vol |
530,000 | |
Filed 2022-10-11 13:04 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
Filed 2022-10-11 13:01 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
Filed 2022-10-11 12:55 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+448,300 vol |
||
Filed 2022-10-11 12:52 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+530,000 vol |
||
Filed 2022-10-11 12:32 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+923,910 vol |
||
Filed 2022-10-11 12:24 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+940,000 vol |
||
Filed 2022-10-11 12:17 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
Filed 2022-10-11 12:13 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+907,900 vol |
||
Filed 2022-10-11 15:44 Tx date 2022-09-30 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+25,000 vol |
50,000 | |
Filed 2022-10-11 15:38 Tx date 2022-09-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+5,000 vol |
32,500 | |
Filed 2022-10-11 15:37 Tx date 2022-09-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+27,500 vol |
27,500 | |
Filed 2022-10-11 14:30 Tx date 2022-09-30 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$100,000 vol |
$200,000 | |
Filed 2022-10-11 14:19 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-11 14:17 Tx date 2022-09-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$20,000 vol |
$130,000 | |
Filed 2022-10-11 14:16 Tx date 2022-05-13 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$110,000 vol |
$110,000 | |
Filed 2022-10-11 14:11 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-11 13:04 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
590,000 | |
Filed 2022-10-11 13:01 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
210,000 | |
Filed 2022-10-11 12:55 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+448,300 vol |
448,300 | |
Filed 2022-10-11 12:53 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-11 12:52 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+530,000 vol |
530,000 | |
Filed 2022-10-11 12:32 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+923,910 vol |
2,197,243 | |
Filed 2022-10-11 12:24 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+940,000 vol |
1,273,333 | |
Filed 2022-10-11 12:20 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
Filed 2022-10-11 12:18 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
Filed 2022-10-11 12:17 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
3,110,000 | |
Filed 2022-10-11 12:13 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+907,900 vol |
1,427,900 | |
Filed 2022-10-11 09:47 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
Filed 2022-10-11 09:47 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-17 12:26 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
||
Filed 2022-08-08 12:51 Tx date 2022-08-08 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,750
+25,000 vol $0.59 each |
1,138,013 | |
Filed 2022-07-11 10:54 Tx date 2022-07-08 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,000
+50,000 vol $0.44 each |
1,113,013 | |
Filed 2022-07-11 10:52 Tx date 2022-07-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,825
+88,500 vol $0.45 each |
1,063,013 | |
Filed 2022-07-11 10:52 Tx date 2022-07-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,567
+3,500 vol $0.4479 each |
974,513 | |
Filed 2022-07-11 10:52 Tx date 2022-07-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,535
+3,500 vol $0.4386 each |
971,013 | |
Filed 2022-07-11 10:51 Tx date 2022-07-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,845
+4,500 vol $0.41 each |
967,513 | |
Filed 2022-06-23 22:24 Tx date 2022-06-20 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$80,000
+166,667 vol $0.48 each |
962,013 | |
Filed 2022-06-23 22:24 Tx date 2022-06-20 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-166,667 vol |
333,333 | |
Filed 2022-06-23 22:22 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2021-09-17 12:30 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-06-22 14:13 Tx date 2022-06-21 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$340.00
+1,000 vol $0.34 each |
796,346 | |
Filed 2022-06-20 14:28 Tx date 2022-06-17 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$622.50
+1,500 vol $0.415 each |
795,346 | |
Filed 2022-06-20 14:28 Tx date 2022-06-17 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$205.00
+500 vol $0.41 each |
793,846 | |
Filed 2022-06-10 12:03 Tx date 2022-06-09 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,332
+16,651 vol $0.56 each |
16,651 | |
Filed 2022-06-10 12:02 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-06-10 11:59 Tx date 2022-06-09 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,161
+16,346 vol $0.56 each |
793,346 | |
Filed 2022-06-10 11:58 Tx date 2022-06-09 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,580
+8,173 vol $0.56 each |
470,673 | |
Filed 2022-04-11 11:07 Tx date 2022-04-08 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,049
+41,500 vol $0.70 each |
3,667,485 | |
Filed 2022-04-05 10:05 Tx date 2022-04-04 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,000
+50,000 vol $0.70 each |
3,625,985 | |
Filed 2022-04-05 09:26 Tx date 2022-04-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+750,000 vol |
777,000 | |
Filed 2022-04-05 09:26 Tx date 2022-04-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-750,000 vol |
0 | |
Filed 2022-04-05 09:24 Tx date 2022-04-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+375,000 vol |
462,500 | |
Filed 2022-04-05 09:24 Tx date 2022-04-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-375,000 vol |
0 | |
Filed 2022-03-31 12:54 Tx date 2022-03-30 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,000
+100,000 vol $0.70 each |
3,575,985 | |
Filed 2022-03-28 13:10 Tx date 2022-03-25 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$91,975
+125,000 vol $0.74 each |
3,475,985 | |
Filed 2022-03-14 18:12 Tx date 2022-03-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$210,000
+300,000 vol $0.70 each |
3,350,985 | |
Filed 2022-03-14 18:11 Tx date 2022-03-11 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$81,500
+100,000 vol $0.81 each |
3,050,985 | |
Filed 2022-03-04 08:53 Tx date 2022-03-03 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,160
+7,000 vol $0.88 each |
27,000 | |
Filed 2021-12-31 18:02 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200,000 vol $1,000 each |
$200,000 | |
Filed 2021-12-31 18:00 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+50,000 vol |
50,000 | |
Filed 2021-12-31 18:00 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-31 17:59 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200,000 vol $1,000 each |
$200,000 | |
Filed 2021-12-31 17:59 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200,000 vol $1,000 each |
||
Filed 2021-12-31 17:59 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-31 17:55 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+47,500 vol |
47,500 | |
Filed 2021-12-31 17:54 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-31 17:53 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$190,000 vol $1,000 each |
$190,000 | |
Filed 2021-12-31 17:53 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-31 17:51 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
25,000 | |
Filed 2021-12-31 17:50 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-31 17:50 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
$100,000 | |
Filed 2021-12-31 17:49 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-11-08 12:46 Tx date 2021-11-05 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,125
+7,500 vol $0.95 each |
87,500 | |
Filed 2021-11-03 11:40 Tx date 2021-11-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,182
+4,100 vol $1.02 each |
80,000 | |
Filed 2021-10-30 18:54 Tx date 2021-10-29 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,018
+5,900 vol $1.02 each |
75,900 | |
Filed 2021-10-28 09:34 Tx date 2021-10-27 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,200
+20,000 vol $1.06 each |
20,000 | |
Filed 2021-10-28 09:33 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-10-27 14:17 Tx date 2021-10-27 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,400
+10,000 vol $1.04 each |
70,000 | |
Filed 2021-10-25 18:04 Tx date 2021-10-22 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+10,000 vol $1.05 each |
60,000 | |
Filed 2021-10-25 18:03 Tx date 2021-10-21 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,800
+20,000 vol $1.09 each |
50,000 | |
Filed 2021-09-21 18:54 Tx date 2021-09-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,840
+14,400 vol $1.10 each |
30,000 | |
Filed 2021-09-17 15:41 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+375,000 vol |
375,000 | |
Filed 2021-09-17 15:39 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-17 12:31 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+750,000 vol |
750,000 | |
Filed 2021-09-17 12:30 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-17 12:26 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
Filed 2021-09-17 12:25 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-17 12:25 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
Filed 2021-09-17 12:23 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-10 10:50 Tx date 2021-08-24 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,119,999
+1,333,333 vol $0.84 each |
1,333,333 | |
Filed 2021-09-10 10:49 Tx date 2021-08-24 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,119,999.72
-1,333,333 vol $0.84 each |
666,667 | |
Filed 2021-09-09 15:18 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
DeGabrielle, Robert Ronald
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-09 15:18 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
DeGabrielle, Robert Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-07 07:23 Tx date 2021-09-03 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,779,417
+1,617,652 vol $1.10 each |
1,617,652 | |
Filed 2021-09-07 07:22 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-13 18:29 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
520,000 | ||
Filed 2021-08-13 18:28 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-13 18:27 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-13 15:37 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
1,945,000 | |
Filed 2021-08-13 15:36 Tx date 2020-12-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
1,925,000 | |
Filed 2021-08-13 15:34 Tx date 2020-05-04 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,500,000 vol |
1,725,000 | |
Filed 2021-08-12 21:24 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
295,000 | |
Filed 2021-08-12 21:23 Tx date 2021-05-13 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
275,000 | |
Filed 2021-08-12 21:20 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
3,020,000 | |
Filed 2021-08-12 21:16 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
120,000 | |
Filed 2021-08-12 21:15 Tx date 2021-05-13 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
Filed 2021-08-12 21:14 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-12 21:09 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
70,000 | |
Filed 2021-08-12 21:08 Tx date 2021-05-13 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2021-08-12 21:07 Tx date 2019-08-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-19 08:56 Tx date 2021-07-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,439
+5,600 vol $1.15 each |
15,600 | |
Filed 2021-06-11 15:05 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
Filed 2021-04-08 12:33 Tx date 2021-04-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+23,256 vol $2.15 each |
204,367 | |
Filed 2021-04-08 12:31 Tx date 2020-12-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,004
+27,000 vol $1.33 each |
181,111 | |
Filed 2021-04-08 12:29 Tx date 2020-07-03 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$32,400
+45,000 vol $0.72 each |
154,111 | |
Filed 2021-02-17 15:01 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
Filed 2021-02-17 15:01 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,000,000 | ||
Filed 2020-12-17 19:11 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,110
-500 vol $2.22 each |
0 | |
Filed 2020-12-17 19:11 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,133
-7,300 vol $2.21 each |
500 | |
Filed 2020-12-17 19:10 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,825
-1,700 vol $2.25 each |
7,800 | |
Filed 2020-12-17 19:08 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-450.00
-200 vol $2.25 each |
9,500 | |
Filed 2020-12-17 19:08 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-227.00
-100 vol $2.27 each |
9,700 | |
Filed 2020-12-17 19:07 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-225.00
-100 vol $2.25 each |
9,800 | |
Filed 2020-12-17 19:07 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-227.00
-100 vol $2.27 each |
9,900 | |
Filed 2020-12-17 19:05 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,400
-5,000 vol $1.88 each |
10,000 | |
Filed 2020-12-17 19:04 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,050
-5,000 vol $1.81 each |
15,000 | |
Filed 2020-12-17 19:03 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,050
-5,000 vol $1.81 each |
20,000 | |
Filed 2020-12-17 19:02 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,600
-5,000 vol $1.72 each |
25,000 | |
Filed 2020-12-17 19:02 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,350
-5,000 vol $1.67 each |
30,000 | |
Filed 2020-12-17 19:01 Tx date 2020-12-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,300
-5,000 vol $1.46 each |
35,000 | |
Filed 2020-12-17 19:01 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,250
-5,000 vol $1.45 each |
40,000 | |
Filed 2020-12-17 19:00 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
45,000 | |
Filed 2020-12-17 19:00 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
||
Filed 2020-12-17 19:00 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,620
-8,500 vol $1.72 each |
||
Filed 2020-12-17 18:59 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,350
-5,000 vol $1.67 each |
||
Filed 2020-12-17 18:59 Tx date 2020-12-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,600
-10,000 vol $1.46 each |
||
Filed 2020-12-17 18:59 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,500
-10,000 vol $1.45 each |
||
Filed 2020-12-17 18:59 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
||
Filed 2020-12-17 17:55 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,620
-8,500 vol $1.72 each |
||
Filed 2020-12-17 17:55 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,620
-8,500 vol $1.72 each |
6,500 | |
Filed 2020-12-17 17:54 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,350
-5,000 vol $1.67 each |
||
Filed 2020-12-17 17:54 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,350
-5,000 vol $1.67 each |
15,000 | |
Filed 2020-12-17 17:36 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,200
-10,000 vol $1.72 each |
||
Filed 2020-12-17 17:36 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,200
-10,000 vol $1.72 each |
||
Filed 2020-12-17 17:35 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,700
-10,000 vol $1.67 each |
||
Filed 2020-12-17 17:35 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,700
-10,000 vol $1.67 each |
||
Filed 2020-12-17 17:33 Tx date 2020-12-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,600
-10,000 vol $1.46 each |
||
Filed 2020-12-17 17:33 Tx date 2020-12-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,600
-10,000 vol $1.46 each |
20,000 | |
Filed 2020-12-17 17:31 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,500
-10,000 vol $1.45 each |
30,000 | |
Filed 2020-12-17 17:31 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,500
-10,000 vol $1.45 each |
||
Filed 2020-12-17 17:30 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
40,000 | |
Filed 2020-12-17 17:30 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
||
Filed 2020-12-17 17:25 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
45,000 | |
Filed 2020-12-17 17:25 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
||
Filed 2020-11-23 09:55 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
25,000 | |
Filed 2020-11-23 09:54 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-23 09:53 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+50,000 vol $0.50 each |
70,000 | |
Filed 2020-06-02 11:34 Tx date 2020-05-27 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
275,000 | |
Filed 2020-06-02 11:32 Tx date 2020-05-27 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-125,000 vol |
125,000 | |
Filed 2020-05-28 15:02 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+109,111 vol |
109,111 | |
Filed 2020-05-28 14:58 Tx date 2019-08-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-28 14:51 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-109,111 vol |
0 | |
Filed 2020-05-28 14:50 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$70,922
+109,111 vol $0.65 each |
109,111 | |
Filed 2020-05-28 14:47 Tx date 2019-08-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 15:05 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+54,555 vol |
354,555 | |
Filed 2020-05-21 15:04 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-54,555 vol |
0 | |
Filed 2020-05-21 15:04 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$35,460
+54,555 vol $0.65 each |
54,555 | |
Filed 2020-05-21 15:03 Tx date 2019-07-22 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 15:01 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+11,538 vol |
461,538 | |
Filed 2020-05-21 15:01 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-11,538 vol |
0 | |
Filed 2020-05-21 15:00 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,499
+11,538 vol $0.65 each |
11,538 | |
Filed 2020-05-21 14:59 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 14:58 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+50,000 vol |
50,000 | |
Filed 2020-05-21 14:55 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 14:51 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-50,000 vol |
0 | |
Filed 2020-05-21 14:50 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$32,500
+50,000 vol $0.65 each |
50,000 | |
Filed 2020-05-21 14:49 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 14:47 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+40,385 vol |
265,385 | |
Filed 2020-05-21 14:46 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-40,385 vol |
0 | |
Filed 2020-05-21 14:45 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$26,250
+40,385 vol $0.65 each |
40,385 | |
Filed 2020-05-21 14:44 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 14:42 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+38,461 vol |
788,461 | |
Filed 2020-05-21 14:41 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-38,461 vol |
0 | |
Filed 2020-05-21 14:40 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$24,999
+38,461 vol $0.65 each |
38,461 | |
Filed 2020-05-21 14:38 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 11:54 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+76,923 vol |
101,923 | |
Filed 2020-05-21 11:53 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-76,923 vol |
0 | |
Filed 2020-05-21 11:52 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$49,999
+76,923 vol $0.65 each |
76,923 | |
Filed 2020-05-21 11:50 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 11:33 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+100,000 vol |
300,000 | |
Filed 2020-05-21 11:30 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-100,000 vol |
0 | |
Filed 2020-05-21 11:29 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$65,000
+100,000 vol $0.65 each |
100,000 | |
Filed 2020-05-21 11:26 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-21 11:09 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-100,000 vol |
0 | |
Filed 2020-05-21 11:07 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+100,000 vol |
150,000 | |
Filed 2020-05-21 11:04 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
36 - Conversion or exchange
|
-100,000 vol |
||
Filed 2020-05-21 11:02 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$65,000
+100,000 vol $0.65 each |
100,000 | |
Filed 2020-05-21 10:57 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-20 15:13 Tx date 2020-05-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Holder: Jaque Capital Management Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,428,000
-1,700,000 vol $0.84 each |
11,102,500 | |
Filed 2020-02-20 14:08 Tx date 2020-02-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Holder: Jaque Capital Management Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-474,000
-200,000 vol $2.37 each |
12,802,500 | |
Filed 2020-01-24 11:41 Tx date 2019-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,000,000,000,000
+1,000,000 vol $1,000,000 each |
5,050,000 | |
Filed 2020-01-24 11:40 Tx date 2019-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
-1,000,000 vol |
500,000 | |
Filed 2020-01-07 13:17 Tx date 2020-01-06 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+50,000 vol $0.50 each |
50,000 | |
Filed 2020-01-07 13:17 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-01-07 13:15 Tx date 2020-01-06 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-50,000 vol |
1,275,000 | |
Filed 2019-12-19 14:44 Tx date 2019-12-19 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,000 vol |
20,000 | |
Filed 2019-12-19 14:42 Tx date 2019-12-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-10,000 vol |
0 | |
Filed 2019-12-13 12:12 Tx date 2019-12-11 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
450,000 | |
Filed 2019-12-13 12:11 Tx date 2019-12-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
0 | |
Filed 2019-11-12 14:45 Tx date 2019-11-05 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+25,000 vol |
412,500 | |
Filed 2019-11-12 14:44 Tx date 2019-11-05 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-25,000 vol |
37,500 | |
Filed 2019-11-08 15:41 Tx date 2019-11-05 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+25,000 vol |
62,500 | |
Filed 2019-10-31 15:32 Tx date 2019-10-09 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,000 vol |
10,000 | |
Filed 2019-10-28 18:59 Tx date 2019-06-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,000 vol |
||
Filed 2019-10-29 08:46 Tx date 2019-07-22 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
Filed 2019-10-29 08:46 Tx date 2019-07-22 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
Filed 2019-10-28 19:05 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-28 19:04 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-28 18:42 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-28 19:42 Tx date 2019-04-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+75,000 vol |
75,000 | |
Filed 2019-10-28 19:41 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-28 19:34 Tx date 2019-04-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
20,000 | |
Filed 2019-10-28 19:24 Tx date 2019-05-23 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
Filed 2019-10-28 19:05 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
Filed 2019-10-28 19:04 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
Filed 2019-10-28 18:59 Tx date 2019-06-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,000 vol |
10,000 | |
Filed 2019-10-28 18:59 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-28 18:58 Tx date 2019-06-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-10,000 vol |
10,000 | |
Filed 2019-10-28 18:57 Tx date 2018-12-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
||
Filed 2019-10-28 18:57 Tx date 2018-12-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
20,000 | |
Filed 2019-10-28 18:57 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-28 18:52 Tx date 2019-06-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,406,250,000
+37,500 vol $37,500 each |
387,500 | |
Filed 2019-10-28 18:51 Tx date 2019-06-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
37,500 | |
Filed 2019-10-28 18:50 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
Filed 2019-10-28 18:50 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-28 18:42 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-28 18:42 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
Filed 2019-10-28 18:36 Tx date 2019-05-24 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
Filed 2019-10-28 18:36 Tx date 2019-05-24 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
||
Filed 2019-10-28 18:35 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
70,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Holder: Jaque Capital Management Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+13,002,500 vol |
13,002,500 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Holder: Jaque Capital Management Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
650,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
1,325,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+100,000 vol |
100,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,125,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Aristizabal, Gonzalo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
25,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
1,275,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+140,000 vol |
140,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
75,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Echavarria Mesa, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
625,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Aristizabal, Gonzalo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2019-01-23 Tx date 2015-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gomez Casas, Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
320,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+25,000 vol |
25,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gomez Casas, Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
100,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Echavarria Mesa, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+750,000 vol |
750,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+350,000 vol |
350,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
225,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,500,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+225,000 vol |
225,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+25,000 vol |
25,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
225,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,250,000 vol |
2,250,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+4,050,000 vol |
4,050,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
2,650,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
175,000 | |
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
2,550,000 | |
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
||
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Human, Delon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
2,600,000 | |
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
||
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,250,000 vol |
2,250,000 | |
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Human, Delon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
||
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+200,000 vol |
200,000 | |
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Human, Delon
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
2,550,000 | |
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Human, Delon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|